Original – Prostate cancer
Reference values of prostate specific antigen (PSA) in 63926 workers without prostatic symptoms who participated in prostate screening cancer developed by the Ibermutuamur Prevention Society in 2006
Valores de referencia del antígeno prostático específico (PSA) en 63.926 trabajadores sin síntomas prostáticos que participaron en el cribado de cáncer de próstata desarrollado por la Sociedad de Prevención de Ibermutuamur durante el año 2006
J.A. Gelpi-Méndez
, E. Gómez-Fernández, J. Martín-Barallat, M.V. Cortés-Arcas, J.V. Monsonis-Artero, A. Calvo-Mora
Corresponding author
Sociedad de Prevención de Ibermutuamur, Madrid, Spain
Read
4103
Timeswas read the article
3972
Total PDF
131
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 52 | 35 | 87 |
| 2025 11 | 0 | 63 | 63 |
| 2025 10 | 0 | 35 | 35 |
| 2025 9 | 0 | 33 | 33 |
| 2025 8 | 0 | 45 | 45 |
| 2025 7 | 0 | 40 | 40 |
| 2025 6 | 0 | 22 | 22 |
| 2025 5 | 0 | 28 | 28 |
| 2025 4 | 0 | 20 | 20 |
| 2025 3 | 0 | 11 | 11 |
| 2025 2 | 0 | 11 | 11 |
| 2025 1 | 0 | 47 | 47 |
| 2024 12 | 0 | 13 | 13 |
| 2024 11 | 0 | 27 | 27 |
| 2024 10 | 0 | 35 | 35 |
| 2024 9 | 0 | 53 | 53 |
| 2024 8 | 0 | 35 | 35 |
| 2024 7 | 0 | 41 | 41 |
| 2024 6 | 0 | 42 | 42 |
| 2024 5 | 0 | 42 | 42 |
| 2024 4 | 0 | 25 | 25 |
| 2024 3 | 0 | 24 | 24 |
| 2024 2 | 0 | 35 | 35 |
| 2024 1 | 0 | 55 | 55 |
| 2023 12 | 0 | 28 | 28 |
| 2023 11 | 0 | 57 | 57 |
| 2023 10 | 0 | 56 | 56 |
| 2023 9 | 0 | 24 | 24 |
| 2023 8 | 0 | 33 | 33 |
| 2023 7 | 0 | 37 | 37 |
| 2023 6 | 0 | 35 | 35 |
| 2023 5 | 0 | 34 | 34 |
| 2023 4 | 0 | 63 | 63 |
| 2023 3 | 1 | 81 | 82 |
| 2023 2 | 0 | 48 | 48 |
| 2023 1 | 0 | 54 | 54 |
| 2022 12 | 0 | 30 | 30 |
| 2022 11 | 0 | 31 | 31 |
| 2022 10 | 0 | 28 | 28 |
| 2022 9 | 0 | 59 | 59 |
| 2022 8 | 0 | 40 | 40 |
| 2022 7 | 0 | 38 | 38 |
| 2022 6 | 0 | 34 | 34 |
| 2022 5 | 0 | 39 | 39 |
| 2022 4 | 0 | 31 | 31 |
| 2022 3 | 0 | 65 | 65 |
| 2022 2 | 0 | 58 | 58 |
| 2022 1 | 0 | 88 | 88 |
| 2021 12 | 0 | 75 | 75 |
| 2021 11 | 0 | 88 | 88 |
| 2021 10 | 0 | 68 | 68 |
| 2021 9 | 0 | 88 | 88 |
| 2021 8 | 0 | 69 | 69 |
| 2021 7 | 0 | 65 | 65 |
| 2021 6 | 0 | 55 | 55 |
| 2021 5 | 0 | 84 | 84 |
| 2021 4 | 0 | 116 | 116 |
| 2021 3 | 0 | 101 | 101 |
| 2021 2 | 0 | 94 | 94 |
| 2021 1 | 0 | 67 | 67 |
| 2020 12 | 0 | 55 | 55 |
| 2020 11 | 0 | 50 | 50 |
| 2020 10 | 0 | 43 | 43 |
| 2020 9 | 0 | 33 | 33 |
| 2020 8 | 0 | 20 | 20 |
| 2020 7 | 0 | 18 | 18 |
| 2020 6 | 0 | 223 | 223 |
| 2020 5 | 0 | 32 | 32 |
| 2020 4 | 0 | 14 | 14 |
| 2020 3 | 0 | 110 | 110 |
| 2020 2 | 0 | 26 | 26 |
| 2020 1 | 0 | 34 | 34 |
| 2019 12 | 0 | 46 | 46 |
| 2019 11 | 0 | 35 | 35 |
| 2019 10 | 0 | 29 | 29 |
| 2019 9 | 0 | 22 | 22 |
| 2019 8 | 0 | 23 | 23 |
| 2019 7 | 0 | 33 | 33 |
| 2019 6 | 0 | 24 | 24 |
| 2019 5 | 0 | 59 | 59 |
| 2019 4 | 0 | 35 | 35 |
| 2019 3 | 0 | 6 | 6 |
| 2019 2 | 0 | 5 | 5 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 0 | 3 | 3 |
| 2018 10 | 0 | 4 | 4 |
| 2018 8 | 0 | 1 | 1 |
| 2018 5 | 0 | 7 | 7 |
| 2018 4 | 0 | 4 | 4 |
| 2018 3 | 0 | 1 | 1 |
| 2018 1 | 0 | 4 | 4 |
| 2017 11 | 2 | 11 | 13 |
| 2017 10 | 2 | 2 | 4 |
| 2017 9 | 4 | 7 | 11 |
| 2017 8 | 7 | 3 | 10 |
| 2017 7 | 4 | 7 | 11 |
| 2017 6 | 4 | 2 | 6 |
| 2017 5 | 8 | 0 | 8 |
| 2017 4 | 3 | 2 | 5 |
| 2017 3 | 2 | 39 | 41 |
| 2017 2 | 2 | 4 | 6 |
| 2016 12 | 5 | 2 | 7 |
| 2016 11 | 6 | 4 | 10 |
| 2016 10 | 17 | 6 | 23 |
| 2016 9 | 4 | 1 | 5 |
| 2016 8 | 6 | 4 | 10 |
| 2016 7 | 2 | 0 | 2 |
Show all
